Sarcoidosis Completed Phase 2 Trials for Ustekinumab (DB05679)

Also known as: Sarcoid / Sarcoidosis, unspecified / Sarcoidosis (disorder) / Boeck's disease / Besnier-Boeck-Schaumann's disease / Schaumann's disease / Sarcoidosis NOS

IndicationStatusPhase
DBCOND0013300 (Sarcoidosis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00955279A Study to Evaluate the Safety and Effectiveness of Ustekinumab or Golimumab Administered Subcutaneously (SC) in Patients With SarcoidosisTreatment